Immune Response News and Research

RSS
Discovering a molecule that could interfere with SARS-CoV-2 replication

Discovering a molecule that could interfere with SARS-CoV-2 replication

Exploring how COVID-19 pandemic trajectory might unfold in the future

Exploring how COVID-19 pandemic trajectory might unfold in the future

Impaired cytotoxic T cell response found in in elderly COVID-19 patients

Impaired cytotoxic T cell response found in in elderly COVID-19 patients

Study detects key differences in immune responses of adults and children with COVID-19

Study detects key differences in immune responses of adults and children with COVID-19

Strength, duration of immunity will shape the future trajectory of COVID-19

Strength, duration of immunity will shape the future trajectory of COVID-19

Novel sequencing method could be useful for COVID-19 research

Novel sequencing method could be useful for COVID-19 research

UM receives $33.4 million for development and clinical trials of opioid vaccines

UM receives $33.4 million for development and clinical trials of opioid vaccines

Enhancing the efficacy of anti-PD-L1 immunotherapy for cancer

Enhancing the efficacy of anti-PD-L1 immunotherapy for cancer

Ineffective immune responses may be responsible for COVID-19 mortality rates in men and the elderly

Ineffective immune responses may be responsible for COVID-19 mortality rates in men and the elderly

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Animal data supports efficacy of baricitinib vs SARS-COV-2

Animal data supports efficacy of baricitinib vs SARS-COV-2

T cells on the front line of COVID-19 response

T cells on the front line of COVID-19 response

Biomarker predicts disease severity in COVID-19 patients

Biomarker predicts disease severity in COVID-19 patients

Study: T cells play a vital role in controlling SARS-CoV-2 during acute phase of infection

Study: T cells play a vital role in controlling SARS-CoV-2 during acute phase of infection

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

UC Davis uses microneedles to deliver gene therapy for retinal diseases

UC Davis uses microneedles to deliver gene therapy for retinal diseases

Self-assembling nanoparticles as a way towards next-generation COVID-19 vaccines

Self-assembling nanoparticles as a way towards next-generation COVID-19 vaccines

Study highlights role of specific protein in the mass production of antibodies

Study highlights role of specific protein in the mass production of antibodies

SARS-CoV-2 infection severity linked to superior humoral immunity against the S-protein

SARS-CoV-2 infection severity linked to superior humoral immunity against the S-protein